MNS1
S. cerevisiae
mannosyl-oligosaccharide 1,2-alpha-mannosidase
What the model saw
Gene: MNS1 Organism: Saccharomyces cerevisiae Known functions: mannosyl-oligosaccharide 1,2-alpha-mannosidase. alpha-mannosidase activity. calcium ion binding. mannosyl-oligosaccharide 1,2-alpha-mannosidase activity.
View unredacted entry
mannosyl-oligosaccharide 1,2-alpha-mannosidase. alpha-mannosidase activity. calcium ion binding. mannosyl-oligosaccharide 1,2-alpha-mannosidase activity.
Solver output
MNS1 encodes a mannosyl-oligosaccharide 1,2-alpha-mannosidase in the ER that trims Man9GlcNAc2 to Man8GlcNAc2 on N-linked glycoproteins. This trimming step is a key quality control checkpoint in the ER-associated degradation (ERAD) pathway, directing misfolded glycoproteins toward proteasomal degradation and thus contributing to proteostasis. While robust ERAD activity supports proteostasis and could be considered pro-longevity, the mannosidase activity of MNS1 specifically promotes the degradation signal for misfolded proteins rather than their folding or retention, making its net effect on longevity ambiguous. Additionally, its calcium ion binding activity is a structural feature common to glycosyl hydrolases and does not clearly map to a longevity pathway. The relationship between N-glycan trimming efficiency and yeast lifespan has not been clearly established in the literature, leaving the directional influence uncertain.
GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.
Advisor judgment
The model predicted "unclear" with low confidence (0.35), but the ground truth is "anti_longevity." The model's reasoning about MNS1's role in ERAD and proteostasis is plausible but ultimately led to an incorrect conclusion. The model failed to identify that MNS1 deletion (loss of function) would extend lifespan, which is the hallmark of an anti-longevity gene. In yeast longevity studies, anti_longevity genes are those whose deletion increases lifespan. The model's mechanistic reasoning about ERAD quality control is partially relevant but doesn't correctly map to the anti-longevity classification. The model was appropriately uncertain but still wrong in its final call.
Raw API responses
solver
{
"reasoning": "MNS1 encodes a mannosyl-oligosaccharide 1,2-alpha-mannosidase in the ER that trims Man9GlcNAc2 to Man8GlcNAc2 on N-linked glycoproteins. This trimming step is a key quality control checkpoint in the ER-associated degradation (ERAD) pathway, directing misfolded glycoproteins toward proteasomal degradation and thus contributing to proteostasis. While robust ERAD activity supports proteostasis and could be considered pro-longevity, the mannosidase activity of MNS1 specifically promotes the degradation signal for misfolded proteins rather than their folding or retention, making its net effect on longevity ambiguous. Additionally, its calcium ion binding activity is a structural feature common to glycosyl hydrolases and does not clearly map to a longevity pathway. The relationship between N-glycan trimming efficiency and yeast lifespan has not been clearly established in the literature, leaving the directional influence uncertain.",
"confidence": 0.35,
"key_pathways": [
"N-glycan processing / ER quality control",
"ER-associated degradation (ERAD)",
"Unfolded protein response (UPR)"
],
"mechanism_class": "loss_of_proteostasis",
"longevity_influence": "unclear"
}advisor
{
"notes": "The model predicted \"unclear\" with low confidence (0.35), but the ground truth is \"anti_longevity.\" The model's reasoning about MNS1's role in ERAD and proteostasis is plausible but ultimately led to an incorrect conclusion. The model failed to identify that MNS1 deletion (loss of function) would extend lifespan, which is the hallmark of an anti-longevity gene. In yeast longevity studies, anti_longevity genes are those whose deletion increases lifespan. The model's mechanistic reasoning about ERAD quality control is partially relevant but doesn't correctly map to the anti-longevity classification. The model was appropriately uncertain but still wrong in its final call.",
"failure_mode": "confident_wrong",
"answer_correct": false,
"mechanism_correct": false,
"reasoning_quality": 2,
"ground_truth_questionable": false
}